John Merhige outlines his key themes shaping drug delivery in 2026: new momentum from a dual-chamber syringe fill-finish collaboration, a newly announced commercial supply agreement with a major global pharma company, and growing pressure to deliver increasingly complex molecules faster and more efficiently.
We caught up with John Merhige from Credence Medsystems live at Pharmapack Europe 2026 to talk momentum in drug delivery. There’s an exciting new collaboration enabling the filling of dual-chamber syringes, alongside a newly announced commercial supply agreement with a major global pharmaceutical company. Looking ahead, the pressures are clear: increasingly complex molecules, tighter budgets, and an uncompromising need for speed to market. What is trending? There is traction on combination therapies that cannot be co-formulated. Sequential dual-chamber delivery is emerging as a practical solution, allowing incompatible liquids to be delivered simultaneously. A great snapshot of where drug delivery is heading in 2026!
